FDANonrulemakingFDA-2018-D-0338
Who commented on this docket
Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act
7 organizations filed 10 public comments on Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act, at the Food and Drug Administration. The comment window closed 3039d ago.
Organizations
7
Comments
10
RIN
—
Comment window
closed 3039d ago
Commenters (7)
- American Pharmacists Association (APhA)trade assoc.2 filings · confidence 97%
- Healthcare Distribution Alliancetrade assoc.2 filings · confidence 85%
- Pharmaceutical Distribution Security Alliancetrade assoc.2 filings · confidence 85%
- Healthcare Supply Chain Associationtrade assoc.1 filing · confidence 85%
- McKesson Corporationunverified attribution1 filing · confidence 70%
- National Association of Boards of Pharmacytrade assoc.1 filing · confidence 85%
- National Association of Chain Drug Storestrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.